Evidence map›Paper›PMID 21969124›Full record

ArticlePsychopharmacology2012

Galanin negatively modulates opiate withdrawal via galanin receptor 1.

Fiona E Holmes, Athena Armenaki, Tiina P Iismaa, Emily B Einstein, John Shine, Marina R Picciotto, David Wynick, Venetia Zachariou

Abstract read
In one paragraph

Article in Psychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Neuronal diversity of neuropeptide signaling, including galanin, in the mouse locus coeruleus.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Fiona E HolmesSchools of Physiology and Pharmacology and Clinical Sciences, University of Bristol, Bristol, UK.
Athena Armenaki
Tiina P Iismaa
Emily B Einstein
John Shine
Marina R Picciotto
David Wynick
Venetia Zachariou
Garvan Institute of Medical Research · AUUniversity of Bristol · GBUniversity of Crete · GRYale University · US

Funding

Galanin-opiate interactionsR01DA015425 · NIDA · YALE UNIVERSITY · PI PICCIOTTO, MARINA R · 2003 to 2012
$3.0M
Medical Research Council G0300028Medical Research Council G1000863NIDA NIH HHS 1R01DA015425-01A1NIDA NIH HHS DA15425NIDA NIH HHS R01 DA015425Wellcome Trust
6 · The paper itself

Abstract

rationaleThe neuropeptide galanin has been shown to modulate opiate dependence and withdrawal. These effects could be mediated via activation of one or more of the three distinct G protein-coupled receptors, namely galanin receptors 1 (GalR1), 2 (GalR2), and 3 (GalR3).

objectivesIn this study, we used several transgenic mouse lines to further define the mechanisms underlying the role played by galanin and its receptors in the modulation of morphine dependence. First, transgenic mice expressing β-galactosidase under the control of the galanin promoter were used to assess the regulation of galanin expression in response to chronic morphine administration and withdrawal. Next, the behavioral responses to chronic morphine administration and withdrawal were tested in mice that over-express galanin, lack the GalR1 gene, or lack the GalR2 gene.

methodsTransgenic and matched wild-type mice were given increasing doses of morphine followed by precipitation of withdrawal by naloxone and behavioral responses to withdrawal were assessed.

resultsBoth morphine administration and withdrawal increased galanin gene transcription in the locus coeruleus (LC). Increasing galanin levels in the brain reduced signs of opiate withdrawal. Mice lacking GalR1 undergo more severe opiate withdrawal, whereas mice lacking GalR2 show no significant difference in withdrawal signs, compare with matched wild-type controls.

conclusionsOpiate administration and withdrawal increase galanin expression in the LC. Galanin opposes the actions of morphine which leads to opiate dependence and withdrawal, an effect that is mediated via GalR1.

Indexed as

AnimalsBehavior, AnimalBrainGalaninGene Expression RegulationMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMorphineNaloxoneNarcotic AntagonistsOpioid-Related DisordersReceptor, Galanin, Type 1Receptor, Galanin, Type 2GalaninMorphineNaloxoneNarcotic AntagonistsReceptor, Galanin, Type 1Receptor, Galanin, Type 2Receptor, Galanin, Type 3

Identifiers

PMID21969124
PMCPMC3324978
OpenAlexW1987520623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.